Literature DB >> 7757288

Tumour fragment spheroids from human non-small-cell lung cancer maintained in organ culture.

L Fjellbirkeland1, R Bjerkvig, O D Laerum.   

Abstract

Biopsy material from 17 human non-small-cell lung carcinomas (NSCLC) was maintained in agar overlay culture as tumour fragment spheroids for 40 days. A practical procedure for the formation of spheroids and organ culture is described. The mechanically dissociated tumour specimens showed a variation in their ability to generate spheroids that was not related to the ploidy or the histological differentiation of the biopsies. Light microscopic observations revealed a heterogeneous spheroid population with a mixture of tumour cells and stromal elements. Most of the histological elements normally found in human NSCLC could be seen in the spheroids. The cellular components in the spheroids varied between highly cellular to sparsely cellular, dominated by stromal elements. The squamous carcinomas were in general found to generate highly cellular spheroids more often than the adenocarcinomas. Spheroids with a different cellular content could be selected in vitro by using a morphometric technique. Diameter measurements showed a large variability in spheroid growth. Most of the spheroids decreased in size although bromodeoxyuridine labelling indicated active cell proliferation in the specimens. Frequent changes of medium did not affect spheroid growth. The culture system presented provides a model for studying the cellular heterogeneity as well as the biological characteristics of tumour tissue from individual patients in vitro.

Entities:  

Mesh:

Year:  1995        PMID: 7757288     DOI: 10.1007/BF00192639

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  28 in total

Review 1.  Lung cancer. Making the diagnosis.

Authors:  S Lyubsky; M J Jacobson
Journal:  Chest       Date:  1991-08       Impact factor: 9.410

2.  Growth of multicell spheroids in tissue culture as a model of nodular carcinomas.

Authors:  R M Sutherland; J A McCredie; W R Inch
Journal:  J Natl Cancer Inst       Date:  1971-01       Impact factor: 13.506

Review 3.  Tumor heterogeneity.

Authors:  G H Heppner
Journal:  Cancer Res       Date:  1984-06       Impact factor: 12.701

4.  Determination of ploidy and proliferative characteristics of human solid tumors by pulse cytophotometry.

Authors:  B Barlogie; W Göhde; D A Johnston; L Smallwood; J Schumann; B Drewinko; E J Freireich
Journal:  Cancer Res       Date:  1978-10       Impact factor: 12.701

5.  Factors that influence initiation and growth of 9L rat brain gliosarcoma multicellular spheroids.

Authors:  Y Sano; D F Deen; T Hoshino
Journal:  Cancer Res       Date:  1982-04       Impact factor: 12.701

6.  Cytokinetic investigation of lung tumors using the anti-bromodeoxyuridine (BUdR) monoclonal antibody method: comparison with DNA flow cytometric data.

Authors:  L Teodori; M L Trinca; W Goehde; J Hemmer; F Salvati; G Storniello; F Mauro
Journal:  Int J Cancer       Date:  1990-06-15       Impact factor: 7.396

7.  Multicellular aggregates from human tumor cell lines for radiation studies.

Authors:  J H Schwachöfer; R P Crooijmans; J L Broers; J Hoogenhout; C R Jerusalem; R Jerusalem; H B Kal; G Mungyer
Journal:  Anticancer Res       Date:  1989 Mar-Apr       Impact factor: 2.480

8.  A three-dimensional micro-organ culture system optimized for in vitro growth of human malignant brain tumors.

Authors:  H W Jung; M E Berens; H G Krouwer; M L Rosenblum
Journal:  Neurosurgery       Date:  1991-09       Impact factor: 4.654

9.  Flow cytometric measurement of p53 protein expression and DNA content in paraffin-embedded tissue from bronchial carcinomas.

Authors:  O Mørkve; O D Laerum
Journal:  Cytometry       Date:  1991

10.  Cytokinetic analysis of lung cancer by in vivo bromodeoxyuridine labelling.

Authors:  M M Tinnemans; B Schutte; M H Lenders; G P Ten Velde; F C Ramaekers; G H Blijham
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

View more
  7 in total

1.  Viable head and neck tumor spheroids stimulate in vitro autologous monocyte MCP-1 secretion through soluble substances and CD14/lectin-like receptors.

Authors:  Carla Olsnes; John-Helge Heimdal; Kenneth W Kross; Jan Olofsson; Hans Jørgen Aarstad
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-11-19       Impact factor: 2.503

2.  Non-small-cell lung carcinoma cells invade human bronchial mucosa in vitro.

Authors:  L Fjellbirkeland; R Bjerkvig; O D Laerum
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-04       Impact factor: 2.416

3.  A novel in vitro model of human mesothelioma for studying tumor biology and apoptotic resistance.

Authors:  Ki-Up Kim; Shannon M Wilson; Keith S Abayasiriwardana; Rodney Collins; Lars Fjellbirkeland; Zhidong Xu; David M Jablons; Stephen L Nishimura; V Courtney Broaddus
Journal:  Am J Respir Cell Mol Biol       Date:  2005-08-25       Impact factor: 6.914

Review 4.  Spherical cancer models in tumor biology.

Authors:  Louis-Bastien Weiswald; Dominique Bellet; Virginie Dangles-Marie
Journal:  Neoplasia       Date:  2015-01       Impact factor: 5.715

5.  Newly characterised ex vivo colospheres as a three-dimensional colon cancer cell model of tumour aggressiveness.

Authors:  L-B Weiswald; S Richon; P Validire; M Briffod; R Lai-Kuen; F P Cordelières; F Bertrand; D Dargere; G Massonnet; E Marangoni; B Gayet; M Pocard; I Bieche; M-F Poupon; D Bellet; V Dangles-Marie
Journal:  Br J Cancer       Date:  2009-07-14       Impact factor: 7.640

6.  Colorectal cancer derived organotypic spheroids maintain essential tissue characteristics but adapt their metabolism in culture.

Authors:  Uros Rajcevic; Jaco C Knol; Sander Piersma; Sébastien Bougnaud; Fred Fack; Eirik Sundlisaeter; Karl Søndenaa; Reidar Myklebust; Thang V Pham; Simone P Niclou; Connie R Jiménez
Journal:  Proteome Sci       Date:  2014-07-11       Impact factor: 2.480

7.  Development of three-dimensional lung multicellular spheroids in air- and liquid-interface culture for the evaluation of anticancer therapeutics.

Authors:  Samantha A Meenach; Alexandra N Tsoras; Ronald C McGarry; Heidi M Mansour; J Zach Hilt; Kimberly W Anderson
Journal:  Int J Oncol       Date:  2016-02-04       Impact factor: 5.650

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.